{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:42:38Z","timestamp":1790073758206,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cca.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T11:01:05Z","timestamp":1586170865000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Clinical utility of serum IgG4 measurement"],"prefix":"10.1016","volume":"506","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-634X","authenticated-orcid":false,"given":"Julia L.","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-8623","authenticated-orcid":false,"given":"Angela W.S.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Mattman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien T.T.","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deonne Thaddeus V.","family":"Gauiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie N.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Y.C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematologica"},{"issue":"9976","key":"10.1016\/j.cca.2020.04.001_b0010","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"9","key":"10.1016\/j.cca.2020.04.001_b0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod. Pathol."},{"issue":"3642","key":"10.1016\/j.cca.2020.04.001_b0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.146.3642.400","article-title":"Subclasses of human \u03b32-globulin based on differences in the heavy polypeptide chains","volume":"146","author":"Terry","year":"1964","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cca.2020.04.001_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.120.2.253","article-title":"H chain subgroups of myeloma proteins and normal 7S \u03b3-globulin","volume":"120","author":"Grey","year":"1964","journal-title":"J. Exp. Med."},{"issue":"3628","key":"10.1016\/j.cca.2020.04.001_b0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1126\/science.145.3628.168","article-title":"Gamma globulin antigenic types defined by heavy chain determinants","volume":"145","author":"Ballieux","year":"1964","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cca.2020.04.001_b0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.semarthrit.2017.03.021","article-title":"Disease associations with isolated elevations of each of the four IgG subclasses","volume":"47","author":"Engelhart","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12349","article-title":"Human IgG4: a structural perspective","volume":"268","author":"Davies","year":"2015","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.166.5.1351","article-title":"Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies","volume":"166","author":"Bruggemann","year":"1987","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2017.282319","article-title":"Resolution of spurious immunonephelometric IgG subclass measurement discrepancies by LC-MS\/MS","volume":"64","author":"van der Gugten","year":"2018","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2020.04.001_b0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.04.001_b0065","article-title":"IgG subclasses and allotypes: from structure to effector functions","author":"Vidarsson","year":"20145","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nyas.13561","article-title":"IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders","volume":"1413","author":"Huijbers","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2020.04.001_b0085","first-page":"3","article-title":"Recognizing IgG4-related tubulointerstitial nephritis","author":"Mann","year":"2016","journal-title":"Can J Kidney Health Dis."},{"key":"10.1016\/j.cca.2020.04.001_b0090","doi-asserted-by":"crossref","unstructured":"Gauiran, Deonne, Marcon, Krista, DeMarco, Mari, et al. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Manuscript in Preparation, 2020.","DOI":"10.1080\/16078454.2020.1815130"},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1309\/AJCP41XCVBHEQCEL","article-title":"Relatively restricted migration of polyclonal IgG4 may mimic a monoclonal gammopathy in IgG4-related disease","volume":"142","author":"Jacobs","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2020.04.001_b0100","article-title":"Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center","author":"Zhao","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4065\/76.5.476","article-title":"Retrospective cohort study of 148 patients with polyclonal gammopathy","volume":"76","author":"Dispenzieri","year":"2001","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ajcp\/aqw113","article-title":"Detection of polyclonal increases in immunoglobulin G4 subclass by distinct patterns on capillary serum protein electrophoresis diagnostic pitfalls and clinical observations in a study of 303 cases","volume":"146","author":"Finn","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.cca.2020.04.001_b0115","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.3324\/haematol.2017.171694","article-title":"Pseudo-monoclonal gammopathy: a report of four cases","volume":"102","author":"Jawad","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2020.04.001_b0120","first-page":"2013","article-title":"Serum immunoglobulin free light chain assessment in IgG4-related disease","author":"Grados","year":"2013","journal-title":"Int. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaci.2005.01.039","article-title":"Determination of IgG subclasses: a need for standardization","volume":"115","author":"Bossuyt","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16\u201317","key":"10.1016\/j.cca.2020.04.001_b0130","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.clinbiochem.2013.07.014","article-title":"Significant, quantifiable differences exist between IgG subclass standards WHO67\/97 and ERM-DA470k and can result in different interpretation of results","volume":"46","author":"Wilson","year":"2013","journal-title":"Clin. Biochem."},{"issue":"8\u20139","key":"10.1016\/j.cca.2020.04.001_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.clinbiochem.2011.01.013","article-title":"Reply to \u201cpediatric reference intervals for immunoglobulin G and its subclasses with Siemens immunonephelometric assays\u201d","volume":"44","author":"Parker","year":"2011","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease: the prozone effect in IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.cca.2020.04.001_b0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","article-title":"Diagnostic approach to the complexity of IgG4-related disease","volume":"90","author":"Stone","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.cca.2020.04.001_b0150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.38668","article-title":"Calibration differences and the prozone phenomenon in IgG4-related disease: comment on the article by Khosroshahi, et al.","volume":"66","author":"Parker","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cei.12805","article-title":"Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease","volume":"186","author":"Egner","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK Cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.cca.2020.04.001_b0170","first-page":"2012","article-title":"Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease","author":"Masaki","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"41","key":"10.1016\/j.cca.2020.04.001_b0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001707","article-title":"Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease","volume":"94","author":"Yu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.cca.2020.04.001_b0180","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/art.38663","article-title":"Corroboration of the prozone phenomenon in IgG4-related disease: comment on the article by Khosroshahi, et al.","volume":"66","author":"Urquhart","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.cca.2020.04.001_b0185","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1373\/clinchem.2018.289124","article-title":"Remediation of IgG4 cross-reactivity in IgG1 and IgG2 subclass assays","volume":"64","author":"Parker","year":"2018","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.cca.2020.04.001_b0190","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/bjophthalmol-2017-310148","article-title":"Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): potential use in IgG4-RD assessment","volume":"101","author":"Chan","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kex371","article-title":"IgG4-related disease presenting with raised serum IgG2\u2014real timeline of IgG4-RD?","volume":"57","author":"Dunkley","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.cca.2020.04.001_b0200","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1373\/clinchem.2014.222208","article-title":"Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography-tandem mass spectrometry","volume":"60","author":"Ladwig","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2020.04.001_b0205","unstructured":"Chen, Luke, Mattman, Andre A, Zhan, Shing, et al. Quality Improvement in IgG4-related Disease Biomarkers: Liquid Chromatography Tandem Mass Spectrometry vs Nephelometry, 2020 (Submitted for publication)."},{"key":"10.1016\/j.cca.2020.04.001_b0210","first-page":"2012","article-title":"Pathologies associated with serum IgG4 elevation","author":"Ebbo","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4269\/ajtmh.1997.56.301","article-title":"Significantly increased IgG2 subclass antibody levels to blastocystis hominis in patients with irritable bowel syndrome","volume":"56","author":"Hussain","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cca.2020.04.001_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/232960","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice","volume":"2012","author":"Ryu","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2020.04.001_b0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1721727X17708940","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with remarkably elevated serum IgG4","volume":"15","author":"Li","year":"2017","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.cca.2020.04.001_b0230","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.201","article-title":"Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions","author":"Chen","year":"2015","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.cca.2020.04.001_b0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajh.21584","article-title":"A young woman with episodic angioedema, papilledema, and eosinophilia","volume":"185","author":"Chen","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2020.04.001_b0240","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ejh.12059","article-title":"IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy","volume":"90","author":"Wong","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cca.2020.04.001_b0245","doi-asserted-by":"crossref","unstructured":"P. Aucouturier J.-L. Preud\u2019homme Subclass distribution of human myeloma proteins as determined with monoclonal antibodies Immunol. Lett. 16 1 1987 55 57 10.1016\/0165-2478(87)90061-7.","DOI":"10.1016\/0165-2478(87)90061-7"},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0250","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.1990.tb05339.x","article-title":"Selective IgG subclass deficiency: quantification and clinical relevance","volume":"81","author":"Jefferis","year":"1990","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2013.159","article-title":"IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease","volume":"27","author":"Geyer","year":"2014","journal-title":"Mod. Pathol."},{"issue":"19","key":"10.1016\/j.cca.2020.04.001_b0260","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-08-663492","article-title":"Immunoglobulin G4-positive plasma cell myeloma","volume":"126","author":"Zhu","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cca.2020.04.001_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14088","article-title":"Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis","volume":"33","author":"Kato","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0270","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14651","article-title":"IgG4-related disease with bone marrow involvement mimicking multiple myeloma","volume":"177","author":"Tang","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0275","first-page":"283","article-title":"Immunoglobulin G4-related disease mimicking multiple myeloma","volume":"32","author":"Costa","year":"2018","journal-title":"Port. J. Nephrol. Amp. Hypertens."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/10408368909106589","article-title":"IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance","volume":"19","author":"Papadea","year":"1989","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0285","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/adc.67.5.628","article-title":"Abnormal serum IgG subclass pattern in children with Down\u2019s syndrome","volume":"67","author":"Anner\u00e9n","year":"1992","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(05)80590-6","article-title":"Deficiency of IgG4 in children: association of isolated IgG4 deficiency with recurrent respiratory tract infection","volume":"120","author":"Moss","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cca.2020.04.001_b0295","article-title":"Basic research and clinical reports associated with low serum IgG4 concentrations","author":"Tian","year":"2019","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.cca.2020.04.001_b0300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1081-1206(10)62152-7","article-title":"The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency","volume":"90","author":"Kalfa","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2500\/108854188778984509","article-title":"IgG4 immunodeficiency","volume":"9","author":"Heiner","year":"1988","journal-title":"N. Engl. Reg. Allergy Proc."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0310","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaip.2013.03.011","article-title":"Relationship of dog- and cat-specific IgE and IgG4 levels to allergic symptoms on pet exposure","volume":"1","author":"Burnett","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.cca.2020.04.001_b0315","first-page":"16","article-title":"Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions","author":"James","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0320","doi-asserted-by":"crossref","first-page":"32035","DOI":"10.1038\/srep32035","article-title":"Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2020.04.001_b0325","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jhbp.194","article-title":"Clinical profiles of patients with primary sclerosing cholangitis in the elderly","volume":"22","author":"Tanaka","year":"2015","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124233","article-title":"Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders","volume":"10","author":"Su","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0335","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"issue":"6","key":"10.1016\/j.cca.2020.04.001_b0340","first-page":"1322","article-title":"Serum level of Ca 19\u20139 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma","volume":"59","author":"van Heerde","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0345","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/acr.22216","article-title":"Elevated IgG4 serum levels among primary Sj\u00f6gren\u2019s syndrome patients: do they unmask underlying IgG4-related disease?","volume":"66","author":"Mavragani","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0350","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/03009742.2013.862567","article-title":"Description of patients with IgG4-related disease from a Hungarian centre","volume":"43","author":"Sz\u00e1nt\u00f3","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cca.2020.04.001_b0355","first-page":"1","article-title":"Distribution characteristics of elevated serum immunoglobulin G4 (IgG4) and its relationship with IgG4-related disease","author":"Yang","year":"2019","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cca.2020.04.001_b0365","first-page":"19","article-title":"New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases","author":"Yamada","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.cca.2020.04.001_b0370","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: baseline clinical and laboratory features in 125 patients with biopsy-proven disease","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amjms.2017.08.014","article-title":"Utility of serum IgG4 levels in a multiethnic population","volume":"355","author":"Qi","year":"2018","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cca.2020.04.001_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2020.03.018","article-title":"Immunoglobulin G (IgG) and IgG subclass concentrations differ according to sex and race","author":"Harkness","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.cca.2020.04.001_b0385","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/key397","article-title":"Sex disparities in clinical characteristics and prognosis of immunoglobulin G4\u2013related disease: a prospective study of 403 patients","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.cca.2020.04.001_b0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.MPA.0000335395.75884.a3","article-title":"Effect of steroid therapy on the serum igg4 levels and the clinical manifestations of autoimmune pancreatitis","volume":"37","author":"Suzuki","year":"2008","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.cca.2020.04.001_b0395","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0400","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cca.2020.04.001_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/annrheumdis-2014-205476","article-title":"IgG4 levels and plasmablasts as a marker for IgG4-related disease (IgG4-RD)","volume":"74","author":"Fox","year":"2015","journal-title":"Ann. Rheum. Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:55:33Z","timestamp":1757861733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120301479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":81,"alternative-id":["S0009898120301479"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of serum IgG4 measurement","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}